The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...

According to the American college of rheumatology, more than 790,000 knee replacements are performed annually in the U.S. and ...

There are multiple chapters near you. Select your preferred chapter.

A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active ...

Long-term treatment with anifrolumab significantly reduced the rate of organ damage compared with SOC among patients with SLE ...

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

Capstan Therapeutics presents preclinical data on lead in vivo CAR-T candidate, CPTX2309, with plans to advance into the ...

today announced that the Company will be presenting a poster at the American College of Rheumatology (the "ACR") Convergence ...

Oral presentation at ACR highlights safety and efficacy data from the Phase 1 trial of umbilical cord outer lining-derived stem cells (ULSCs) ...

NKTR-422 demonstrated inflammation resolution and tissue repair in multiple preclinical models of chronic inflammatory conditions - SAN FRANCISCO, Nov. 18, 2024 ...

Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.